Filippo Crea
doi : 10.1093/eurheartj/ehac161
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1443–1446
Judith Ozkan
doi : 10.1093/eurheartj/ehab740
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1447–1449
Hein Heidbuchel, Isabelle C Van Gelder, Lien Desteghe, for the EHRA-PATHS Investigators
doi : 10.1093/eurheartj/ehab672
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1450–1452
doi : 10.1093/eurheartj/ehab752
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1453–1454
Giovanna Liuzzo, Massimo Volpe
doi : 10.1093/eurheartj/ehac081
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1455–1456
Eloi Marijon, Rodrigue Garcia, Kumar Narayanan, Nicole Karam, Xavier Jouven
doi : 10.1093/eurheartj/ehab903
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1457–1464
More than 40 years after the first implantable cardioverter-defibrillator (ICD) implantation, sudden cardiac death (SCD) still accounts for more than five million deaths worldwide every year. Huge efforts in the field notwithstanding, it is now increasingly evident that the current strategy of long-term prevention based on left ventricular ejection fraction as the key selection criterion is actually of very limited impact, also because the largest absolute numbers of SCD are encountered in the general population not known to be at risk. It has been recently reemphasized that SCD is often not so sudden, with almost half of the victims experiencing typical warning symptoms preceding the event. Importantly, heeded and prompt medical attention can dramatically improve survival. Essentially, such timely action increases the chances of the SCD event being witnessed by emergency medical services and provides the opportunity for early intervention. In addition, newer technologies incorporating digital data acquisition, transfer between interconnected devices, and artificial intelligence, should allow dynamic, real-time monitoring of diverse parameters and therefore better identification of subjects at short-term SCD risk. Along with warning symptoms, these developments allow a new approach of near-term prevention based on the hours and minutes preceding SCD. In the present review, we challenge the current paradigm of mid- and long-term prevention using ICD in patients at the highest risk of SCD, and introduce a complementary concept applicable to the entire population that would aim to pre-empt SCD by timely detection and intervention within the minutes or hours prior to the event.
Remy Stieglis, Jolande A Zijlstra, Frank Riedijk, Martin Smeekes, Wim E van der Worp, Jan G P Tijssen, Aeilko H Zwinderman, Marieke T Blom, Rudolph W Koster
doi : 10.1093/eurheartj/ehab802
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1465–1474
Automated external defibrillators (AEDs) are placed in public, but the majority of out-of-hospital cardiac arrests (OHCA) occur at home.
Carolina Malta Hansen, Fredrik Folke
doi : 10.1093/eurheartj/ehac028
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1475–1477
Sofia Schierbeck, Jacob Hollenberg, Anette Nord, Leif Svensson, Per Nordberg, Mattias Ringh, Sune Forsberg, Peter Lundgren, Christer Axelsson, Andreas Claesson
doi : 10.1093/eurheartj/ehab498
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1478–1487
Early defibrillation is critical for the chance of survival in out-of-hospital cardiac arrest (OHCA). Drones, used to deliver automated external defibrillators (AEDs), may shorten time to defibrillation, but this has never been evaluated in real-life emergencies. The aim of this study was to investigate the feasibility of AED delivery by drones in real-life cases of OHCA.
Nicole Karam, Daniel Jost, Xavier Jouven, Eloi Marijon
doi : 10.1093/eurheartj/ehab565
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1488–1490
Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
doi : 10.1093/eurheartj/ehab822
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1491–1499
Cardiovascular disease is a common complication in acromegaly. We investigated the risk of cardiovascular disease and mortality in patients with acromegaly in a large-scale population using nationwide data in Korea.
Roddy Walsh, Arnon Adler, Ahmad S Amin, Emanuela Abiusi, Melanie Care, Hennie Bikker, Simona Amenta, Harriet Feilotter, Eline A Nannenberg, Francesco Mazzarotto, Valentina Trevisan, John Garcia, Ray E Hershberger, Marco V Perez, Amy C Sturm, James S Ware, Wojciech Zareba, Valeria Novelli, Arthur A M Wilde, Michael H Gollob
doi : 10.1093/eurheartj/ehab687
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1500–1510
Catecholaminergic polymorphic ventricular tachycardia (CPVT) and short QT syndrome (SQTS) are inherited arrhythmogenic disorders that can cause sudden death. Numerous genes have been reported to cause these conditions, but evidence supporting these gene–disease relationships varies considerably. To ensure appropriate utilization of genetic information for CPVT and SQTS patients, we applied an evidence-based reappraisal of previously reported genes.
Minoru Horie, Seiko Ohno, Tomohiko Ai
doi : 10.1093/eurheartj/ehab794
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Pages 1511–1513
Zi-Xuan Yang, Ying Xu, Xuan Chen, Qing Zhang
doi : 10.1093/eurheartj/ehab639
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Page 1514
Kosuke Tsuda, Yumiko Kanzaki, Masaaki Hoshiga
doi : 10.1093/eurheartj/ehab730
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Page 1515
Rodrigo Fernández Asensio, Isaac Pascual Calleja, Cesar Moris de la Tassa, Santiago Colunga Blanco
doi : 10.1093/eurheartj/ehab763
European Heart Journal, Volume 43, Issue 15, 14 April 2022, Page 1516
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟